The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Garov E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Garova E.E.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Pryakhina M.A.

Pirogov Russian National Research Medical University

Corticosteroids for acute sensorineural hearing loss treatment. The contemporary state of problem. Literature review. Part 1

Authors:

Garov E.V., Garova E.E., Pryakhina M.A.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2022;87(3): 51‑56

DOI: 10.17116/otorino20228703151

Read: 4449 times

Download PDF (RU)
Contact the author
Table of contents

CORTICOSTEROIDS FOR ACUTE SENSORINEURAL HEARING LOSS TREATMENT. THE CONTEMPORARY STATE OF PROBLEM. LITERATURE REVIEW. PART 1
CORTICOSTEROIDS FOR ACUTE SENSORINEURAL HEARING LOSS TREATMENT. THE CONTEMPORARY STATE OF PROBLEM. LITERATURE REVIEW. PART 1

To cite this article:

Garov EV, Garova EE, Pryakhina MA. Corticosteroids for acute sensorineural hearing loss treatment. The contemporary state of problem. Literature review. Part 1. Russian Bulletin of Otorhinolaryngology. 2022;87(3):51‑56. (In Russ.)
https://doi.org/10.17116/otorino20228703151

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

ABSTRACT

The article presents modern literary data relating to the expediency of the purpose of glucocorticosteroids in sudden sensorineural hearing loss (SSHL) of various genes. In detail, the radar molecular mechanisms and the anatomo-physiological features of the exposure to the inner ear, side effects, the introduction methods, their comparative efficacy and modern schemes of the SSHL.

Keywords:

acute sensorineural hearing loss
glucocorticosteroids
treatment

Authors:

Garov E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

Garova E.E.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

Pryakhina M.A.

Pirogov Russian National Research Medical University

Received:

13.08.2021

Accepted:

07.10.2021

Close metadata

References:

  1. Kunelskaya NL. Krovoobrashcheniye golovnogo mozga i nejrosensornaya tugoukhost’ (klinicheskiye, audiologicheskiye i angiograficheskie issledovaniya): Diss. ... d-ra med. nauk. M. 1995. Accessed August 01, 2021. (In Russ.). https://dlib.rsl.ru/01000309248
  2. Klinicheskie rekomendatsii Minzdrava Rossii. Sensonevral’naya tugoukhost’ u vzroslykh. 2016. Accessed August 01, 2021. (In Russ). https://www.nmaoru.org/files/KR518%20Sensonevralnaja%20tugouhost%20u%20vzroslyh.pdf
  3. Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, Hollingsworth DB, Kelley DM, Kmucha ST, Moonis G, Poling GL, Roberts JK, Stachler RJ, Zeitler DM, Corrigan MD, Nnacheta LC, Satterfield L. Clinical practice guideline: sudden hearing loss (Update). Otolaryngology — Head and Neck Surgery. 2019;161(1 Suppl):1-45.  https://doi.org/10.1177/0194599819859885
  4. Vincent R, Sperling NM, Oates J, Jindal M. Surgical findings and long-term hearing results in 3,050 stapedotomies for primary otosclerosis: A prospective study with the otology-neurotology database. Otology and Neurotology. 2006;27(8 Suppl 2):25-47.  https://doi.org/10.1097/01.mao.0000235311.80066.df
  5. Vincent R, Rovers M, Zingade N, Oates J, Sperling N, Devèze A, Grolman W. Revision stapedotomy: operative findings and hearing results. A prospective study of 652 cases from the otology-neurotology database. Otology and Neurotology. 2010;31(6): 875-882.  https://doi.org/10.1097/MAO.0b013e3181e8f1da
  6. Çelik Ç, Ceylan M, Aliyeva A, Düzenli U, Dalgıç A. The effect of perioperative i.v. corticosteroids on hearing outcome following stapedotomy. ENT Updates. 2018;8(2):82-87.  https://doi.org/10.32448/entupdates.458981
  7. Singh A, Kumar Irugu D. Sudden sensorineural hearing loss — a contemporary review of management issues. Journal of Otology. 2019;15(2):67-73.  https://doi.org/10.1016/j.joto.2019.07.001
  8. Qian Y, Zhong S, Hu G, Kang H, Wang L, Lei Y. Sudden sensorineural hearing loss in children: A report of 75 cases. Otology and Neurotology. 2018;39(8):1018-1024. https://doi.org/10.1097/MAO.0000000000001891
  9. Pitaro J, Bechor-Fellner A, Gavriel H, Marom T, Eviatar E. Sudden sensorineural hearing loss in children: etiology, management, and outcome. International Journal of Pediatric Otorhinolaryngology. 2016;82:34-37.  https://doi.org/10.1016/j.ijporl.2015.12.022
  10. Lechner M, Sutton L, Ferguson M, Abbas Y, Sandhu J, Shaida A. Intratympanic steroid use for sudden sensorineural hearing loss: current otolaryngology practice. The Annals of Otology, Rhinology, and Laryngology. 2019;128(6):490-502.  https://doi.org/10.1177/0003489419828759
  11. Klinicheskie rekomendatsii Minzdrava Rossii. Sensonevral’naya tugoukhost’ u detej. 2016. Accessed August 01, 2021. (In Russ.). https://www.nmaoru.org/files/KR22%20Sensonevralnaja%20tugouhost%20u%20detej.pdf
  12. Klinicheskie rekomendatsii Natsional’noj meditsinskoj Assotsiatsii otorinolaringologov. Sensonevral’naya tugoukhost’. 2014. Accessed August 01, 2021. (In Russ.). https://www.nmaoru.org/files/Sensonevralnaja%20tugouhost%202014.pdf
  13. Vishnyakov VV, Sorokina MV. Transtimpanal’noe vvedenie steroidov pri lechenii ostroj nejrosensornoj tugoukhosti. Vestnik otorinolaringologii. 2014;4:55-58. (In Russ.).
  14. Kosyakov SYa, Atanesyan AG, Gunenkov AV. Local therapy of acute sensorineural hearing loss by intrampanal administration of steroids. Vestnik otolaringologii. 2012;3:74-78. (In Russ.).
  15. Wei B, Stathopoulos D, O’Leary S. Steroids for idiopathic sudden sensorineural hearing loss. The Cochrane Database of Systematic Reviews. 2013;2013(7):CD003998. https://doi.org/10.1002/14651858.CD003998.pub3
  16. Conlin A, Parnes L. Treatment of sudden sensorineural hearing loss: I. A systematic review Arch. Archives of Otolaryngology — Head and Neck Surgery. 2007;133(6):573-581.  https://doi.org/10.1001/archotol.133.6.573
  17. Conlin A, Parnes L. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis Arch. Archives of Otolaryngology — Head and Neck Surgery. 2007;133(6):582-586.  https://doi.org/10.1001/archotol.133.6.582
  18. Cinamon U, Bendet E, Kronenberg J. Steroids, carbogen or placebo for sudden hearing loss: A prospective double-blind study. European Archives of Oto-Rhino-Laryngology. 2001;258(9):477-480.  https://doi.org/10.1007/s004050100366
  19. Nosrati-Zarenoe R., Hultcrantz E. Corticosteroid treatment of idiopathic sudden sensorineural hearing loss: randomized triple‐blind placebo‐controlled trial. Otology and Neurotology. 2012;33(4): 523-531.  https://doi.org/10.1097/MAO.0b013e31824b78da
  20. Leung M, Flaherty A, Zhang J, Hara J, Barber W, Burgess L. Sudden sensorineural hearing loss: primary care update. Hawai’i Journal of Medicine and Public Health. 2016;75(6):172-174. 
  21. Plontke S. Diagnostics and therapy of sudden hearing loss. GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery. 2018;16:Doc05. https://doi.org/10.3205/cto000144
  22. Vlastarakos P, Papacharalampous G, Maragoudakis P, Kampessis G, Maroudias N, Candiloros D, Nikolopoulos T. Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice. European Archives of Oto-Rhino-Laryngology. 2012;269(2):363-380.  https://doi.org/10.1007/s00405-011-1738-0
  23. Wilson W, Byl F, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study. Archives of Otolaryngology. 1980;106(12):772-776.  https://doi.org/10.1001/archotol.1980.00790360050013
  24. Filipo R, Attanasio G, Russo F, Viccaro M, Mancini P, Covelli E. Intratympanic steroid therapy in moderate sudden hearing loss: A randomized, triple-blind, placebo-controlled trial. Laryngoscope. 2013;123(3):774-778.  https://doi.org/10.1002/lary.23678
  25. Trune D, Canlon B. Corticosteroid therapy for hearing and balance disorders. Anatomical Record. 2012;295(11):1928-1943. https://doi.org/10.1002/ar.22576
  26. Lee J, Choi S, Park K, Park H, Choo O, Choung Y. The efficiency of intratympanic dexamethasone injection as a sequential treatment after initial systemic steroid therapy for sudden sensorineural hearing loss. European Archives of Oto-Rhino-Laryngology. 2011;268(6):833-839.  https://doi.org/10.1007/s00405-010-1476-8
  27. MacArthur C, Hausman F, Kempton B, Trune D. Intratympanic steroid treatments may improve hearing via ion homeostasis alterations and not immune suppression. Otology and Neurotology. 2015;36(6):1089-1095. https://doi.org/10.1097/MAO.0000000000000725
  28. Trune D, Shives K, Hausman F, Kempton J, MacArthur C, Choi D. Intratympanically delivered steroids impact thousands more inner ear genes than systemic delivery. The Annals of Otology, Rhinology, and Laryngology. 2019;128(6 Suppl):134-138.  https://doi.org/10.1177/0003489419837562
  29. Ermutlu G, Süslü N, Yılmaz T, Saraç S. Sudden hearing loss: An effectivity comparison of intratympanic and systemic steroid treatments. European Archives of Oto-Rhino-Laryngology. 2017;274(10):3585-3591. https://doi.org/10.1007/s00405-017-4691-8
  30. Rauch SD, Halpin CF, Antonelli PJ, Babu S, Carey JP, Gantz BJ, Goebel JA, Hammerschlag PE, Harris JP, Isaacson B, Lee D, Linstrom CJ, Parnes LS, Shi H, Slattery WH, Telian SA, Vrabec JT, Reda DJ. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: A randomized trial. JAMA. 2011;305(20):2071-2079. https://doi.org/10.1001/jama.2011.679
  31. Lai D, Zhao F, Jalal N, Zheng Y. Intratympanic glucocorticosteroid therapy for idiopathic sudden hearing loss: meta-analysis of randomized controlled trials. Medicine. 2017;96(50):e8955. https://doi.org/10.1097/MD.0000000000008955
  32. Dispenza F, Amodio E, De Stefano A, Gallina S, Marchese D, Mathur N, Riggio F. Treatment of sudden sensorineural hearing loss with transtympanic injection of steroids as single therapy: A randomized clinical study. European Archives of Oto-Rhino-Laryngology. 2011;268(9):1273-1278. https://doi.org/10.1007/s00405-011-1523-0
  33. Creber N, Eastwood H, Hampson A, Tan J, O’Leary S. A comparison of cochlear distribution and glucocorticoid receptor activation in local and systemic dexamethasone drug delivery regimes. Hearing Research. 2018;368:75-85.  https://doi.org/10.1016/j.heares.2018.03.018
  34. Lee J, Jang J, Choo O, Lim H, Choung Y. Steroid intracochlear distribution differs by administration method: systemic versus intratympanic injection. Laryngoscope. 2018;128(1):189-194.  https://doi.org/10.1002/lary.26562
  35. Wang Y, Han L, Diao T, Jing Y, Wang L, Zheng H, Ma X, Qi J, Yu L. A comparison of systemic and local dexamethasone administration: from perilymph/cochlea concentration to cochlear distribution. Hearing Research. 2018;370:1-10.  https://doi.org/10.1016/j.heares.2018.09.002
  36. Kakehata S, Sasaki A, Futai K, Kitani R, Shinkawa H. Daily short-term intratympanic dexamethasone treatment alone as an initial or salvage treatment for idiopathic sudden sensorineural hearing loss. Audiology and Neuro-Otology. 2011;16(3):191-197.  https://doi.org/10.1159/000320269
  37. Filipo R, Covelli E, Balsamo G, Attanasio G. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: A new protocol. Acta Oto-Laryngologica. 2010;130(11):1209-1213. https://doi.org/10.3109/00016481003793766
  38. Kakehata S, Sasaki A, Oji K, Futai K, Ota Sh, Makinae K, Shinkawa H. Comparison of intratympanic and intravenous dexamethasone treatment on sudden sensorineural hearing loss with diabetes. Otology and Neurotology. 2006;27(5):604-608.  https://doi.org/10.1097/01.mao.0000224092.79635.ee
  39. Bird P, Begg E, Zhang M, Keast A, Murray D, Balkany T. Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Otology and Neurotology. 2007;28(8):1124-1130. https://doi.org/10.1097/MAO.0b013e31815aee21
  40. Bird P, Murray D, Zhang M, Begg E. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otology and Neurotology. 2011;32(6):933-936.  https://doi.org/10.1097/MAO.0b013e3182255933
  41. Tsai Y, Liang J, Wu W, Ding Y, Chiang R, Wu S. Intratympanic injection with dexamethasone for sudden sensorineural hearing loss. The Journal of Laryngology and Otology. 2011;125(2):133-137.  https://doi.org/10.1017/S0022215110002124
  42. Hong S, Park C, Lee J. Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL. Otolaryngology — Head and Neck Surgery. 2009;141(5):579-583.  https://doi.org/10.1016/j.otohns.2009.08.009
  43. Ahn J, Han M, Kim J, Chung J, Yoon T. Therapeutic effectiveness over time of intratympanic dexamethasone as salvage treatment of sudden deafness. Acta Oto-Laryngologica. 2008;128(2):128-131.  https://doi.org/10.1080/00016480701477602
  44. Choung Y, Park K, Shin Y, Cho M. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope. 2006;116(5):747-752.  https://doi.org/10.1097/01.mlg.0000205183.29986.f6
  45. Selivanova O, Gouveris H, Victor A, Amedee R, Mann W. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière’s-associated sudden sensorineural hearing loss. Otology and Neurotology. 2005;26(5):890-895.  https://doi.org/10.1097/01.mao.0000185050.69394.48
  46. Gouveris H, Selivanova O, Mann W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. European Archives of Oto-Rhino-Laryngology. 2005;262(2):131-134.  https://doi.org/10.1007/s00405-004-0772-6
  47. Slattery W, Fisher L, Iqbal Z, Friedman R, Liu N. Intratympanic steroid injection for treatment of idiopathic sudden hearing loss. Otolaryngology — Head and Neck Surgery. 2005;133(2):251-259.  https://doi.org/10.1016/j.otohns.2005.05.015
  48. Gundogan O, Pinar E, Imre A, Ozturkcan S, Cokmez O, Yigiter AC. Therapeutic efficacy of the combination of intratympanic methylprednisolone and oral steroid for idiopathic sudden deafness. Otolaryngology — Head and Neck Surgery. 2013;149(5):753-758.  https://doi.org/10.1177/0194599813500754
  49. Battaglia A, Burchette R, Cueva R. Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss. Otology and Neurotology. 2008;29(4):453-460.  https://doi.org/10.1097/MAO.0b013e318168da7a
  50. Ahmadzai N, Kilty S, Cheng W, Esmaeilisaraji L, Wolfe D, Bonaparte JP, Schramm D, Fitzpatrick E, Lin V, Skidmore B, Moher D, Hutton B. A systematic review and network meta-analysis of existing pharmacologic therapies in patients with idiopathic sudden sensorineural hearing loss. PLoS One. 2019;14(9):e0221713. https://doi.org/10.1371/journal.pone.0221713
  51. Battaglia A, Lualhati A, Lin H, Burchette R, Cueva R. A prospective, multi-centered study of the treatment of idiopathic sudden sensorineural hearing loss with combination therapy versus high-dose prednisone alone: A 139 patient follow-up. Otology and Neurotology. 2014;35(6):1091-1098. https://doi.org/10.1097/MAO.0000000000000450
  52. Demirhan H, Gökduman A, Hamit B, Yürekli Altındağ M, Yiğit Ö. Contribution of intratympanic steroids in the primary treatment of sudden hearing loss. Acta Oto-Laryngologica. 2018;138(7):648-651.  https://doi.org/10.1080/00016489.2018.1438660
  53. Ahn J, Yoo M, Yoon T, Chung J. Can intratympanic dexamethasone added to systemic steroids improve hearing outcome in patients with sudden deafness? Laryngoscope. 2008;118(2):279-282.  https://doi.org/10.1097/MLG.0b013e3181585428
  54. Niedermeyer H, Zahneisen G, Luppa P, Busch R, Arnold W. Cortisol levels in the human perilymph after intravenous administration of prednisolone. Audiology and Neuro-Otology. 2003;8:316-321.  https://doi.org/10.1159/000073516
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.